Study Status: Active, not recruiting
Recruit Status: Active, not recruiting
Study Type: Interventional
Official Title: A Phase I Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Advanced Laryngeal Cancer
Brief Summary: single-modality phase I dose escalation toxicity study for first-line curative treatment of head and neck squamous cell carcinoma.